Parasomnias due to medications or substances

The Parasomnias and Other Sleep-Related Movement Disorders

Volumn , Issue , 2010, Pages 42-53

  Cartwright, Rosalind D ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898541935     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511711947.008     Document Type: Chapter

References (57)

1. American Academy of Sleep Medicine. International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Rochester, Mn: American Academy of Sleep Medicine, 2001.
2. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd edition: Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine. 2006.
3. Kales A, Soldatos CR, Bixler EO, et al. Hereditary factors in sleepwalking and night terrors. Br J Psychiatry 1980; 137: 111-8.
4. Hublin C, Kaprio J, Heikkila K, et al. Prevalence and genetics of sleepwalking: A population-based twin study. Neurology 1997; 48: 177-81.
5. Lecendreux M, Bassetti C, Dauvilliers Y, et al. HLA and genetic susceptibility to sleepwalking. Mol Psychiatry 2003; 8: 114-7.
6. Gaudreau H, Joncas S, Zadra A, et al. Dynamics of slow wave sleep during the NREM sleep of sleepwalkers and control subjects. Sleep 2000; 23: 755-60.
7. Espa F, Ondze B, Deglise P, et al. Sleep architecture, slow wave activity and sleep spindles in adult patients with sleepwalking and sleep terrors. Clin Neurophys2000; 111: 929-39.
8. Guilleminault C, Poyares D, Abat F, et al. Sleep wakefulness in somnambulism: A spectral analysis study. JPsychosom Res 2001; 51: 411-6.
9. Ohayon M, Guilleminault C, Priest RG. Night terrors, sleepwalking and confusional arousals in the general population: Their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 1999; 60: 268-76.
10. Lam SP, Fong SYY, Ho CKW, et al. Parasomnia among psychiatric outpatients: A clinical, epidemiologic, cross-sectional study. J Clin Psychiat2008; 69: 1374-82.
11. Huapaya LVM. Seven cases of somnambulism induced by drugs. Am J Psychiatry 1979; 136: 985-6.
12. Charney DS, Kales A, Soldatos CR, et al.Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. Br J Psychiatry 1979; 135: 418-24.
13. Glassman JN, Darko D, Gillin JC. Medication-induced somnambulism in a patient with schizoaffective disorder. J Clin Psychiatry 1986; 47: 523-4.
14. Landry P, Warnes H, Nielsen T, et al.Somnambulistic-like behavior in patients attending a lithium clinic. IntClin Psychopharm 1999; 14: 173-5.
15. Kupfer DJ, Reynolds CF III, Weiss BL, et al. Lithium carbonate and sleep in affective disorders: Further considerations. Arch Gen Psychiatry 1974; 30: 79-84.
16. Luchins DJ, Sherwood PM, Gillin CJ, et al. Filicide during psychotropic-induced somnambulism: A case report. Am J Psychiatry 1978; 135: 1404-05.
17. Broughton RJ. NREM arousal parasomnias. In Kryger MH, Roth T, Dement WC (Eds), Principles and Practice of Sleep Medicine, 3rd edition. Philadelphia, PA: W.B. Saunders Co., 2000; 693-706.
18. Kolivakis TT, Margolese HC, Beauclair L, et al.Olanzapine-induced somnambulism. Am J Psychiatry2001; 158: 1158.
19. Paquet V, Strul J, Servais L. Sleep-related eating disorder induced by olanzapine. J Clin Psychiatry 2002; 63: 597.
20. Sharpley AL, Vassallo CM, Cowann JP. Olanzapine increases slow-wave sleep: Evidence for blockade of central 5HT2c receptors in vivo. Biol Psychiatry 2000; 47: 468-70.
21. Flemenbaum A. Pavor nocturnes: A complication of single daily tricyclic or neuroleptic dosage. Am J Psychiatry 1976; 133: 570-2.
22. Alao AO, Yolles JC, Armenta WC, et al.Somnambulism precipitated by selective-reuptake inhibitors. Pharm Techno 1999; 15: 204-07.
23. Kawashima T, Yomada S. Paroxetine-induced somnambulism. J Clin Psychiatry 2003; 64: 483.
24. Fernando-Santos JA, Mataix-Sanjuan AL. Amytriptyline and somnambulism. Ann Pharmacother2000; 34: 1208.
25. Borbely AA, Mattmann P, Strauch I, et al. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 1985; 4: 189-94.
26. Mendelson WB. Hypnotic medications: Mechanisms of action and pharmacological effects. In Kryger MH, Roth T, Dement W (Eds), Principles and Practice of Sleep Medicine, 4th edition. Philadelphia, PA: WB Saunders Co., 2005; 444-51.
27. Poitras R. A propos depisodes damnesies anterogrades associes a l’utilisation du triazolam. Union Med Can 1980; 109: 427-9.
28. Menkes DB. Triazolam-induced nocturnal bingeing with amnesia. Austral NZ J Psychiatry 1992; 26: 320-1.
29. Laurema H. Nocturnal wandering caused by restless legs and short-acting benzodiazepines. Act Psychiatry Scand 1991; 83: 492-3.
30. Schenck CH, Hurwitz TD, Bundlie SR, et al.Sleep-related eating disorders: Polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep 1991; 14: 419-31.
31. Regenstein QA, Reich P. Agitation observed during treatment with newer hypnotic drugs. J Clin Psychiatry1985; 46: 280-3.
32. Lemoine P, Lamothe P, Ohayon MM. Violence, sleep and benzodiazepines. Am J Foren Psychiatry 1997; 18: 17-26.
33. Mendelson WB. Sleepwalking associated with zolpidem. J Clin Psychopharmacol 1994; 34: 150.
34. Harazin J, Berigan TR. Zolpidem tartrate and somnambulism. Mil Med 1999; 164: 669-70.
35. Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem - sleepwalking: A case report. Arch Phys Med Rehabil 2005; 86: 1265-6.
36. Sattar SP. Somnambulism due to probable interaction of valporic acid and zolpidem. Ann Pharmacother2003; 37: 1429-33.
37. Morganthaler TI, Silber MH. Amnestic sleep-related eating disorder is associated with zolpidem. Sleep Med2002; 3: 323-7.
38. Sansone RA, Sansone LA. Zolpidem, somnambulism, and nocturnal eating - Letter to the editor. Gen Hospital Psychiatry 2008; 30: 90-1.
39. Tsai MJ, Tsai YH, Huang YB. Compulsive activity and antegrade amnesia after zolpidem use. Clin Toxicol2007; 45: 179-81.
40. Tsai YH, Yang B, Chen CC, et al. Zolpidem-induced amnesia and somnambulism: Rare occurrences? Eur Neuropsychopharm 2009; 19: 74-6.
41. Landolt H-P, Finelli LA, Roth C, et al. Zolpidem and sleep deprivation: Different effect on EEC power spectra. J Sleep Res 2000; 9: 175-83.
42. Erman MK, Zamit G, Rubens R, et al. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med 2008; 4: 229-34.
43. Kripke DF. Who should sponsor sleep disorders pharmaceutical trials? J Clin Sleep Med 2007; 3: 671-3.
44. Bonkalo A. Impulsive acts and confusional states during incomplete arousal from sleep: Criminological and forensic implications. Psychiatry Quar 1974; 48: 400-09.
45. Tachibana M, Tanka K, Hishikawa Y, et al. A sleep study of acute psychotic states due to alcohol and meprobamate addiction. Adv Sleep Res 1975; 2: 177-205.
46. Moldofsky H, Gilbert R, Lue FA, et al. Sleep-related violence. Sleep 1995; 18: 731-9.
47. Pressman M, Mahowald MW, Schenck CH, et al.Alcohol-induced sleepwalking or confusional arousal as a defense to criminal behavior: A review of scientific evidence, methods and forensic considerations. J Sleep Res 2007; 16: 198-212.
48. Shwierin B, Borbely AA, Tobler I. Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 1996; 300: 163-71.
49. Wurts SW, Edgar DM. Caffeine during sleep deprivation: sleep tendency and dynamics of recovery sleep in rats. Pharmacol Biochem Behav 2000; 65: 155-62.
50. Howard C, D’Orban PT. Violence in sleep: Medico-legal issues and two case reports. Psychol Med1987; 17: 915-25.
51. Stolz SE, Aldrich MS. REM behavior disorder associated with caffeine abuse. Sleep Res Online 1991; 20: 341.
52. Nash JR, Wilson SJ, Potokar JP, et al. Mitrazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 2003; 61: 1161.
53. Schenck CH, Mahowald MW, Kim SW, et al.Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992; 15: 226-35.
54. Armitage R, Triveti M, Rush AJ. Fluoxetine and ocularmotor activity during sleep in depressed patients. Neuropsychopharmacology 1995; 12: 159-65.
55. Dorsey, CM, Lukas SE, Cunningham SI. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 1996; 14: 437-42.
56. Schenck CH, Boyd J, Mahowald MW. A parasomnia overlap disorder involving sleepwalking sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep 1997; 20: 972-81.
57. Cartwright R. Letter to the Editor re: Pressman M. Factors that predispose, prime and precipitate NREM parasomnias in adults. Sleep Med Revs 2008; 12: 77-80.